Wordt geladen...
A novel dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetes
AIMS/HYPOTHESIS: The metabolic syndrome is a cluster of risk correlates that can progress to type 2 diabetes. The present study aims to evaluate a novel molecule with a dual action against the metabolic syndrome and type 2 diabetes. METHODS: We developed and tested a novel dual modulator, RB394, whi...
Bewaard in:
| Gepubliceerd in: | Diabetologia |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6563928/ https://ncbi.nlm.nih.gov/pubmed/30032428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-018-4685-0 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|